Universita Humanitas
- Address
- Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Italy
Universita Humanitas - Advanced Oncology & Precision Medicine Research
Universita Humanitas is a leading academic medical research institution specializing in precision oncology and advanced imaging technologies. The center conducts cutting-edge clinical trials focused on improving outcomes for patients with metastatic cancers through innovative treatment strategies and sophisticated diagnostic approaches, including PSMA-PET imaging and FDG-PET/CT response monitoring.
- Metastatic prostate cancer treatment combining targeted therapies with surgical interventions
- Advanced imaging protocols for metastatic breast cancer response monitoring and survival optimization
- Endocrine disorders including novel therapeutic approaches for Graves' Disease
The research center demonstrates particular expertise in integrating molecular imaging biomarkers with therapeutic decision-making, conducting multicenter randomized trials that compare conventional versus advanced imaging modalities. Their comprehensive approach spans both solid tumor malignancies and autoimmune endocrine conditions, emphasizing evidence-based treatment optimization and patient-centered outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Immunovant Sciences GmbH2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Immunovant Sciences GmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universita Humanitas
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized Study of IMVT-1402 Versus Placebo in Adult Patients with Graves' Disease | Immunovant Sciences GmbH | Phase II | Recruiting | Nov 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| IMEROPRUBART | 2 | Unknown | 2025-11-21 | 2026-05-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.